NYSE:ATRPackaging
AptarGroup (ATR) Margin Compression Challenges Bullish Pharma Growth Narrative In Q1 2026
AptarGroup (ATR) opened 2026 with Q1 revenue of US$982.9 million and basic EPS of US$1.13, while trailing twelve month revenue stood at US$3.9 billion and EPS at US$5.93, setting a clear benchmark for the latest quarter against its recent run rate. Over the past five reported quarters, revenue has moved from US$887.3 million in Q1 2025 to US$982.9 million in Q1 2026, with quarterly EPS ranging between US$1.13 and US$1.95 over that stretch. This gives investors a consistent view of how the top...